SLC27A4 and cancer: No significantly different levels of SLC27A4 were shown among all cancer stages; however, significant differences between luminal vs. triple negative (p < 0.0001) and HER2 positive vs. triple negative (p = 0.0180) in different subtype analysis, and Caucasian vs. African American (p = 0.0013) and Caucasian vs. Asian (p = 0.0174) in different race analysis were observed.